Endocrine and Metabolic Comorbidities in Juvenile-Onset Systemic Lupus Erythematosus

    February 2025 in “ Frontiers in Medicine
    Su Jin Park, Moon Bae Ahn, Dae Chul Jeong
    Image
    Studysummary This study found that patients with juvenile-onset systemic lupus erythematosus have a high prevalence of endocrine and metabolic comorbidities, particularly dyslipidemia and obesity-related issues, suggesting the need for routine monitoring and obesity prevention.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Patients with juvenile-onset systemic lupus erythematosus (JSLE) experience a higher incidence of endocrine and metabolic comorbidities. Regular monitoring of these patients is recommended to manage and potentially reduce these health burdens. Additionally, preventing obesity in JSLE patients may be beneficial in decreasing the risk of developing these comorbid conditions.
    Discuss this study in the Community โ†’

    Research cited in this study

    4 / 4 results